AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

BACKGROUND: AHNAK, also known as desmoyokin, is a giant protein with the molecular size of approximately 700 kDa and exerts diverse functions in different types of cancer. RESULTS: In the present study, we demonstrated that AHNAK mRNA levels were down-regulated in 7 out of 8 human breast cancer cell...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Exp Clin Cancer Res
Main Authors: Chen, Bo, Wang, Jin, Dai, Danian, Zhou, Qingyu, Guo, Xiaofang, Tian, Zhi, Huang, Xiaojia, Yang, Lu, Tang, Hailin, Xie, Xiaoming
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427595/
https://ncbi.nlm.nih.gov/pubmed/28494797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0522-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki